Drug Trial Radar · NCT05486728
Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
Last checked: Nov 19, 2026Latest source record: Oct 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
85
Actual
Start
Feb 8, 2023
Primary completion
Dec 7, 2023
Study completion Dec 7, 2023
Sponsor
- Lead sponsor
- Dreamhawk Vision Biotech, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 4, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to measure efficacy and safety with SHJ002 sterile ophthalmic solution compared to vehicle in participants with Dry Eye Disease (DED). SHJ002 is an antisense oligonucleotide to neutralize a specific microRNA.
Conditions
- Dry Eye Disease
Interventions
SHJ002/VehicleDrug
Topical ophthalmic
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Total Corneal Fluorescein Staining (NEI Scale)Time frame: Baseline and Day 84
Locations
4 sites in 3 countries. Site status is shown where the registry gives one.
Australian Eye Specialists
Werribee, Victoria, Australia
Kaohsiung Veterans General Hospital
Kaohsiung City, Kaohsiung, Taiwan
King Chulalongkorn Memorial Hospital
Bangkok, Thailand
Ramathibodi Hospital, Mahidol University
Bangkok, Thailand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.